Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma
- PMID: 31558288
- DOI: 10.1016/j.jhep.2019.07.024
Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma
Comment in
-
Reply to: "Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma".J Hepatol. 2019 Dec;71(6):1262-1263. doi: 10.1016/j.jhep.2019.08.033. Epub 2019 Sep 26. J Hepatol. 2019. PMID: 31564445 No abstract available.
Comment on
-
Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma.J Hepatol. 2019 Jul;71(1):104-114. doi: 10.1016/j.jhep.2019.03.013. Epub 2019 Mar 23. J Hepatol. 2019. PMID: 30910538
Similar articles
-
Reply to: "Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma".J Hepatol. 2019 Dec;71(6):1262-1263. doi: 10.1016/j.jhep.2019.08.033. Epub 2019 Sep 26. J Hepatol. 2019. PMID: 31564445 No abstract available.
-
Cholangiocarcinoma.Surg Pathol Clin. 2018 Jun;11(2):403-429. doi: 10.1016/j.path.2018.02.005. Surg Pathol Clin. 2018. PMID: 29751883 Review.
-
Mass-forming intrahepatic cholangiocarcinoma presenting tumor growth in extrahepatic bile duct and superficial spreading.Hepatogastroenterology. 2003 Jan-Feb;50(49):21-3. Hepatogastroenterology. 2003. PMID: 12629982
-
Left hemihepatectomy and caudate lobectomy and complete extrahepatic bile duct resection using transduodenal approach for hilar cholangiocarcinoma arsing from biliary papillomatosis.J Surg Oncol. 2008 Aug 1;98(2):139-42. doi: 10.1002/jso.21089. J Surg Oncol. 2008. PMID: 18521837
-
Extrahepatic cholangiocarcinoma: current surgical strategy.Surg Oncol Clin N Am. 2009 Apr;18(2):269-88, viii. doi: 10.1016/j.soc.2008.12.003. Surg Oncol Clin N Am. 2009. PMID: 19306812 Review.
Cited by
-
Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes.Hepatol Int. 2023 Oct;17(5):1300-1317. doi: 10.1007/s12072-023-10556-3. Epub 2023 Jun 27. Hepatol Int. 2023. PMID: 37368186 Free PMC article.
-
HMGA1 augments palbociclib efficacy via PI3K/mTOR signaling in intrahepatic cholangiocarcinoma.Biomark Res. 2023 Mar 29;11(1):33. doi: 10.1186/s40364-023-00473-w. Biomark Res. 2023. PMID: 36978140 Free PMC article.
-
Identification of immune related gene signature for predicting prognosis of cholangiocarcinoma patients.Front Immunol. 2023 Feb 2;14:1028404. doi: 10.3389/fimmu.2023.1028404. eCollection 2023. Front Immunol. 2023. PMID: 36817485 Free PMC article.
-
Selecting an Appropriate Experimental Animal Model for Cholangiocarcinoma Research.J Clin Transl Hepatol. 2022 Aug 28;10(4):700-710. doi: 10.14218/JCTH.2021.00374. Epub 2022 Feb 11. J Clin Transl Hepatol. 2022. PMID: 36062286 Free PMC article. Review.
-
NNMT promotes the progression of intrahepatic cholangiocarcinoma by regulating aerobic glycolysis via the EGFR-STAT3 axis.Oncogenesis. 2022 Jul 18;11(1):39. doi: 10.1038/s41389-022-00415-5. Oncogenesis. 2022. PMID: 35851575 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
